BR112013000907A2 - composição, partícula nanodimensionada para uso em registro de imagem de raios-x e método para tratamento de uma condição ou doença associada ao crescimento indesejável de células em um indivíduo com necessidade dele - Google Patents
composição, partícula nanodimensionada para uso em registro de imagem de raios-x e método para tratamento de uma condição ou doença associada ao crescimento indesejável de células em um indivíduo com necessidade deleInfo
- Publication number
- BR112013000907A2 BR112013000907A2 BR112013000907A BR112013000907A BR112013000907A2 BR 112013000907 A2 BR112013000907 A2 BR 112013000907A2 BR 112013000907 A BR112013000907 A BR 112013000907A BR 112013000907 A BR112013000907 A BR 112013000907A BR 112013000907 A2 BR112013000907 A2 BR 112013000907A2
- Authority
- BR
- Brazil
- Prior art keywords
- treating
- individual
- composition
- condition
- need
- Prior art date
Links
- 230000010261 cell growth Effects 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 238000003384 imaging method Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000002105 nanoparticle Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/48—Diagnostic techniques
- A61B6/481—Diagnostic techniques involving the use of contrast agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0033—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room
- A61B5/0035—Features or image-related aspects of imaging apparatus classified in A61B5/00, e.g. for MRI, optical tomography or impedance tomography apparatus; arrangements of imaging apparatus in a room adapted for acquisition of images from more than one imaging mode, e.g. combining MRI and optical tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0071—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by measuring fluorescence emission
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
- A61B5/0075—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence by spectroscopy, i.e. measuring spectra, e.g. Raman spectroscopy, infrared absorption spectroscopy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/032—Transmission computed tomography [CT]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/02—Arrangements for diagnosis sequentially in different planes; Stereoscopic radiation diagnosis
- A61B6/03—Computed tomography [CT]
- A61B6/037—Emission tomography
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B8/00—Diagnosis using ultrasonic, sonic or infrasonic waves
- A61B8/48—Diagnostic techniques
- A61B8/481—Diagnostic techniques involving the use of contrast agent, e.g. microbubbles introduced into the bloodstream
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/04—X-ray contrast preparations
- A61K49/0409—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is not a halogenated organic compound
- A61K49/0414—Particles, beads, capsules or spheres
- A61K49/0423—Nanoparticles, nanobeads, nanospheres, nanocapsules, i.e. having a size or diameter smaller than 1 micrometer
- A61K49/0428—Surface-modified nanoparticles, e.g. immuno-nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/103—Treatment planning systems
- A61N5/1039—Treatment planning systems using functional images, e.g. PET or MRI
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1064—Monitoring, verifying, controlling systems and methods for adjusting radiation treatment in response to monitoring
- A61N5/1065—Beam adjustment
- A61N5/1067—Beam adjustment in real time, i.e. during treatment
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B6/00—Apparatus or devices for radiation diagnosis; Apparatus or devices for radiation diagnosis combined with radiation therapy equipment
- A61B6/40—Arrangements for generating radiation specially adapted for radiation diagnosis
- A61B6/4064—Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam
- A61B6/4092—Arrangements for generating radiation specially adapted for radiation diagnosis specially adapted for producing a particular type of beam for producing synchrotron radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N5/00—Radiation therapy
- A61N5/10—X-ray therapy; Gamma-ray therapy; Particle-irradiation therapy
- A61N5/1048—Monitoring, verifying, controlling systems and methods
- A61N5/1049—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam
- A61N2005/1061—Monitoring, verifying, controlling systems and methods for verifying the position of the patient with respect to the radiation beam using an x-ray imaging system having a separate imaging source
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Medical Informatics (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Surgery (AREA)
- Nanotechnology (AREA)
- High Energy & Nuclear Physics (AREA)
- Epidemiology (AREA)
- Optics & Photonics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Crystallography & Structural Chemistry (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Hematology (AREA)
- Theoretical Computer Science (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Radiation-Therapy Devices (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US36491710P | 2010-07-16 | 2010-07-16 | |
EP10169862 | 2010-07-16 | ||
PCT/EP2011/062122 WO2012007567A1 (en) | 2010-07-16 | 2011-07-15 | Nanoparticle-guided radiotherapy |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112013000907A2 true BR112013000907A2 (pt) | 2017-10-31 |
Family
ID=43063934
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112013000907A BR112013000907A2 (pt) | 2010-07-16 | 2011-07-15 | composição, partícula nanodimensionada para uso em registro de imagem de raios-x e método para tratamento de uma condição ou doença associada ao crescimento indesejável de células em um indivíduo com necessidade dele |
Country Status (9)
Country | Link |
---|---|
US (1) | US20130204121A1 (pt) |
EP (1) | EP2593186A1 (pt) |
JP (1) | JP2013532629A (pt) |
CN (1) | CN103079642A (pt) |
AU (1) | AU2011278308B2 (pt) |
BR (1) | BR112013000907A2 (pt) |
CA (1) | CA2804849A1 (pt) |
MX (1) | MX2013000501A (pt) |
WO (1) | WO2012007567A1 (pt) |
Families Citing this family (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10064960B2 (en) | 2011-11-25 | 2018-09-04 | Danmarks Tekniske Universitet | Formulation of solid nano-sized particles in a gel-forming system |
US9370490B2 (en) | 2012-02-28 | 2016-06-21 | Loma Linda University | Methods for the production, modification and use of metallic nanoparticles |
US10231684B2 (en) | 2012-05-02 | 2019-03-19 | Koninklijke Philips N.V. | Spectral CT visualization of imageable drug eluting beads |
US10035009B2 (en) | 2013-04-15 | 2018-07-31 | The Board Of Trustees Of The Leland Stanford Junior University | Systems and methods for treating pancreatic cancer |
EP3003397B1 (en) * | 2013-05-24 | 2020-08-19 | Danmarks Tekniske Universitet (DTU) | Gel formulations for guiding radiotherapy |
FR3018451A1 (fr) * | 2014-03-13 | 2015-09-18 | Chromalys | Nanoparticules pour leur utilisation dans la detection de tumeurs mobiles |
CN103894557B (zh) * | 2014-03-19 | 2016-01-20 | 丽水市中心医院 | 磁共振成像下可视的功能化金纳米粒子的制备方法及应用 |
US10004695B2 (en) | 2014-04-16 | 2018-06-26 | Trustees Of Boston University | GM3 functionalized nanoparticles |
US9814791B2 (en) | 2014-07-01 | 2017-11-14 | Augusta University Research Institute, Inc. | Bio-compatible radiopaque dental fillers for imaging |
CN106463387B (zh) * | 2014-12-02 | 2019-06-28 | 希玛科技有限公司 | 采用微型纳米气泡的清洗方法和清洗装置 |
US20160199661A1 (en) * | 2015-01-13 | 2016-07-14 | Boston Scientific Scimed, Inc. | Cancer cell membrane depolarization |
JPWO2016137013A1 (ja) * | 2015-02-26 | 2017-12-14 | 国立大学法人北海道大学 | 放射線治療用の病変識別マーカーおよび放射線治療用の病変識別マーカーキット |
WO2017155948A1 (en) * | 2016-03-07 | 2017-09-14 | Memorial Sloan Kettering Cancer Center | Bone marrow-, reticuloendothelial system-, and/or lymph node-targeted radiolabeled liposomes and methods of their diagnostic and therapeutic use |
EP3456815A4 (en) * | 2016-05-13 | 2019-11-27 | Sigma-Technology Inc. | AQUEOUS SOLUTION THAT CAN BE ADMINISTERED TO A LIVING BODY AND METHOD FOR ITS PRODUCTION |
ES2812820T3 (es) | 2016-08-16 | 2021-03-18 | Eth Zuerich | Polimerosomas de gradiente de pH transmembrana y su uso en la eliminación del amoníaco y sus análogos metilados |
US20190201557A1 (en) * | 2016-08-25 | 2019-07-04 | National University Corporation Hokkaido University | Lesion identification marker utilizing bone cement for use in radiation therapy, and lesion identification marker kit for use in radiation therapy |
US11147986B2 (en) * | 2017-08-04 | 2021-10-19 | The Cleveland Clinic Foundation | Temporally feathered radiation therapy |
WO2019053578A1 (en) | 2017-09-12 | 2019-03-21 | Eth Zurich | TRANSMEMBRANE PH GRADIENT POLYMERSOMES FOR THE QUANTIFICATION OF AMMONIA IN BODY FLUIDS |
FR3099052B1 (fr) * | 2019-07-23 | 2022-03-25 | Univ Franche Comte | Structures particulaires à base de nanoparticules d’or, leurs procédés de préparation et leurs utilisations dans le traitement des tumeurs solides |
US10929981B1 (en) * | 2019-08-21 | 2021-02-23 | Ping An Technology (Shenzhen) Co., Ltd. | Gross tumor volume segmentation method and computer device |
BR112022004337A2 (pt) * | 2019-09-09 | 2022-08-23 | Univ La Frontera | Sistema integral de fontes de ortovoltagem que induzem radiação ionizante |
CN111467174B (zh) * | 2019-12-20 | 2023-02-17 | 联影(常州)医疗科技有限公司 | 一种头部固定装置、血管减影造影系统及透射方法 |
IT202000001048A1 (it) | 2020-01-21 | 2021-07-21 | Univ Degli Studi Padova | Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici. |
IT202100001049A1 (it) | 2021-01-21 | 2022-07-21 | Univ Degli Studi Padova | Nanoparticelle multifunzionali a base di nanoleghe metalliche per usi diagnostici e terapeutici. |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6818199B1 (en) * | 1994-07-29 | 2004-11-16 | James F. Hainfeld | Media and methods for enhanced medical imaging |
WO2000006244A2 (en) * | 1998-07-30 | 2000-02-10 | Hainfeld James F | Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
JP4282302B2 (ja) * | 2001-10-25 | 2009-06-17 | 株式会社東芝 | X線ct装置 |
AU2002351240A1 (en) * | 2002-03-08 | 2003-09-22 | James Hainfeld | Gold nanoparticles used for x-rays imaging |
WO2004017814A2 (en) | 2002-08-23 | 2004-03-04 | The Board Of Regents Of University Of Texas System | Novel method and composition of identifying inflammation by cat scan |
GB2395882B (en) * | 2002-11-28 | 2006-06-14 | Elekta Ab | Radiotherapy apparatus and operating method |
JP4247533B2 (ja) * | 2003-09-03 | 2009-04-02 | 国立大学法人東京工業大学 | 呼吸同期装置 |
WO2005046733A1 (en) * | 2003-11-17 | 2005-05-26 | Philips Intellectual Property & Standards Gmbh | Contrast agent for medical imaging techniques and usage thereof |
US20070031337A1 (en) * | 2004-06-22 | 2007-02-08 | Reinhard Schulte | Nanoparticle enhanced proton computed tomography and proton therapy |
EP1848464B1 (en) | 2005-02-11 | 2014-04-23 | University Health Network | Compositions and methods for multimodal imaging |
DE102005018330B4 (de) * | 2005-04-20 | 2007-04-19 | Siemens Ag | System zur Erzeugung von CT-Bilddatensätzen und zur Bestrahlung eines Tumor-Patienten |
GB0519391D0 (en) * | 2005-09-22 | 2005-11-02 | Aion Diagnostics Ltd | Imaging agents |
WO2007129311A2 (en) | 2006-05-04 | 2007-11-15 | Pan Sci Tech S.A. | Nano-particles with contrast agents for diagnostic delivery system for x-ray and ct |
KR100810679B1 (ko) * | 2006-05-09 | 2008-03-07 | 원광대학교산학협력단 | 금 나노입자를 이용한 엑스-선 조영제 및 이의 제조방법 |
US7906147B2 (en) * | 2006-10-12 | 2011-03-15 | Nanoprobes, Inc. | Functional associative coatings for nanoparticles |
US20080213189A1 (en) * | 2006-10-17 | 2008-09-04 | The Board Of Trustees Of The Leland Stanford Junior University | Multifunctional metal-graphite nanocrystals |
US20100119458A1 (en) * | 2007-02-07 | 2010-05-13 | Spago Imaging Ab | Compositions Containing Metal Oxide Particles and Their Use |
US20090088625A1 (en) * | 2007-10-01 | 2009-04-02 | Kenneth Oosting | Photonic Based Non-Invasive Surgery System That Includes Automated Cell Control and Eradication Via Pre-Calculated Feed-Forward Control Plus Image Feedback Control For Targeted Energy Delivery |
EP2209420A4 (en) * | 2007-10-09 | 2014-01-22 | Univ St Louis | IMAGING PARTICLES |
WO2009073193A2 (en) * | 2007-12-03 | 2009-06-11 | The Johns Hopkins University | Methods of synthesis and use of chemospheres |
WO2009155431A1 (en) * | 2008-06-18 | 2009-12-23 | University Of Louisville Research Foundation, Inc. | Methods for targeted cancer treatment and detection |
US8784800B2 (en) * | 2009-03-09 | 2014-07-22 | Medtronic, Inc. | Method of delivering cell therapy to a target site |
PL2449379T3 (pl) * | 2009-07-02 | 2017-12-29 | Sloan-Kettering Institute For Cancer Research | Fluorescencyjne nanocząstki na bazie krzemionki |
-
2011
- 2011-07-15 US US13/810,588 patent/US20130204121A1/en not_active Abandoned
- 2011-07-15 BR BR112013000907A patent/BR112013000907A2/pt not_active IP Right Cessation
- 2011-07-15 JP JP2013519107A patent/JP2013532629A/ja active Pending
- 2011-07-15 CN CN2011800423725A patent/CN103079642A/zh active Pending
- 2011-07-15 EP EP11731392.4A patent/EP2593186A1/en not_active Withdrawn
- 2011-07-15 CA CA2804849A patent/CA2804849A1/en not_active Abandoned
- 2011-07-15 AU AU2011278308A patent/AU2011278308B2/en not_active Ceased
- 2011-07-15 MX MX2013000501A patent/MX2013000501A/es unknown
- 2011-07-15 WO PCT/EP2011/062122 patent/WO2012007567A1/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
EP2593186A1 (en) | 2013-05-22 |
WO2012007567A1 (en) | 2012-01-19 |
AU2011278308B2 (en) | 2014-09-04 |
CN103079642A (zh) | 2013-05-01 |
JP2013532629A (ja) | 2013-08-19 |
AU2011278308A1 (en) | 2013-01-31 |
CA2804849A1 (en) | 2012-01-19 |
MX2013000501A (es) | 2013-06-05 |
US20130204121A1 (en) | 2013-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR112013000907A2 (pt) | composição, partícula nanodimensionada para uso em registro de imagem de raios-x e método para tratamento de uma condição ou doença associada ao crescimento indesejável de células em um indivíduo com necessidade dele | |
BRPI1009381A2 (pt) | compostos, composição farmacêutica, método para tratar doença ou condição associada com função de trap1 em sujeito em necessidade do mesmo e uso de compostos e composição farmacêutica | |
BRPI0816097A2 (pt) | composição farmacêutica, método para tratar eritema em um paciente com rosácea, e, uso de uma composição. | |
BR112015003397A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente. | |
BR112015003332A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
BR112015003398A2 (pt) | composto, composição farmacêutica, uso do composto e método para tratar uma doença ou condição mediada por rorgammat em um paciente | |
BRPI1016147A2 (pt) | sistema intrauterino para uso no tratamento de uma condição médica, e, método para a fabricação de um sistema intrauterino | |
EP2282672A4 (en) | SYSTEMS AND METHOD FOR ILLUSTRATING TISSUE CHANGES | |
BRPI1004899A2 (pt) | composto, composição farmacêutica, método para tratar uma doença ou distúrbio relacionado a pi3k em um indivíduo necessitando do mesmo, método para tratar uma doença mediada por mtor, método para tratar ambas as doenças mediadas por pi3k e hdac | |
BRPI0908503A2 (pt) | partícula com um diâmetro menor que 2mm, e, composição para o tratamento de tecidos | |
BRPI1011413A2 (pt) | sistema, método e marcador luminescente para geração de imagem luminescente difusa melhorada ou tomografia em meio de dispersão | |
ZA201305498B (en) | Methods and compositions suitable for managing blood glucose in animals | |
BR112013022927A2 (pt) | composição, métodos para substituir ou suplementar ou modificar uma microbiota do cólon de um sujeito, e para tratar um sujeito, e, uso de uma composição | |
BR112013009483A2 (pt) | "estrutura substancialmente desprovida de celulose para utilização em um artigo absorvente, artigo absorvente e método de fabricação de uma estrutura abosrvente" | |
BRPI0821859A2 (pt) | Composição para cuidado oral, uso de um aminoácido básico, em forma livre ou de sal, e, método para aumentar a distribuição de um agente antibacteriano em uma composição para cuidado oral | |
HK1189792A1 (zh) | 接合增強的植入物、系統和方法 | |
BRPI0814503A2 (pt) | composto, uso de um composto, métodos para produzir um efeito anti-proliferativo em um animal de sangue quente, e para tratar uma doença, e, composição farmacêutica | |
BRPI0915986A2 (pt) | composição, métodos para tratar uma condição, para retardar o início de uma condição, para reduzir o risco em um indivíduo de adquirir uma condição e para alterar a expressão de um ou mais genes em um indivíduo | |
EP2561340A4 (en) | Method and system for use in performing security screening | |
IL225597A0 (en) | Pharmaceutical preparation, methods of treatment and its uses | |
EP3072536A4 (en) | Hydrophilic electrospinning biological composite stent material used for tissue regeneration and preparation method and application thereof | |
BRPI0912292A2 (pt) | composições e métodos para o uso de células no tratamento do tecido cardíaco. | |
EP2344041A4 (en) | Method and device for performing computed tomography x-ray imaging | |
PL2468319T3 (pl) | Nowy nanoprodukt przydatny w zabiegach profilaktycznych, diagnostycznych oraz leczniczych w medycynie ludzkiej i w weterynarii | |
BRPI0919643A2 (pt) | aparelho de formação de imagem de raio-x, e, método para formar imagem de raio-x |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B15I | Others concerning applications: loss of priority |
Free format text: PERDA DA PRIORIDADE US 61/364,917 DE 16/07/2010 REIVINDICADA NO PCT/EP2011/062122, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 7O, ITEM 28 DO ATO NORMATIVO 128/97 E NO ART. 29 DA RESOLUCAO INPI-PR 77/2013. ESTA PERDA SE DEU PELO FATO DE O DEPOSITANTE CONSTANTE DA PETICAO DE REQUERIMENTO DO PEDIDO PCT ("TECHNICAL UNIVERSITY OF DENMARK") SER DISTINTO DAQUELES QUE DEPOSITARAM A PRIORIDADE REIVINDICADA E NAO FOI APRESENTADO DOCUMENTO COMPROBATORIO DE CESSAO, CONFORME AS DISPOSICOES PREVISTAS NA LEI 9.279 DE 14/05/1996 (LPI) ART. 16 6O, ITEM 27 DO ATO NORMATIVO 128/97 E NO ART. 2 DA RESOLUCAO INPI-PR 179/2017. |
|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] | ||
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] |
Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI |
|
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 8A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2523 DE 14-05-2019 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |